Literature DB >> 23850540

Phytochemistry and biological properties of glabridin.

Charlotte Simmler1, Guido F Pauli, Shao-Nong Chen.   

Abstract

Glabridin, a prenylated isoflavonoid of G. glabra L. roots (European licorice, Fabaceae), has been associated with a wide range of biological properties such as antioxidant, anti-inflammatory, anti-atherogenic, regulation of energy metabolism, estrogenic, neuroprotective, anti-osteoporotic, and skin-whitening. While glabridin is one of the most studied licorice flavonoids, a comprehensive literature survey linked to its numerous bioactivities is unavailable. The present review provides a comprehensive description of glabridin as a key chemical and biological marker of G. glabra, by covering both its phytochemical characterization and reported biological activities. Both glabridin and standardized licorice extracts have significant impact on food, dietary supplements (DSs) and cosmetic markets, as evidenced by the amount of available patents and scientific articles since 1976, when glabridin was first described. Nevertheless, a thorough literature survey also reveals that information about the isolation and chemical characterization of this important marker is scattered and less detailed than expected. Accordingly, the first part of this review gathers and provides all analytical and spectroscopic data required for the comprehensive phytochemical characterization of glabridin. The four most frequently described and most relevant bioactivities of glabridin are its anti-inflammatory, anti-atherogenic, estrogenic-like effects, and its capacity to regulate energy metabolism. While all bioactivities reported for glabridin belong to a wide array of targets, its principal biological properties are likely interconnected. To this end, the current state of the literature suggests that the biological activity of glabridin mainly results from its capacity to down-regulate intracellular reactive oxygen species, bind to antioxidant effectors, and act on estrogen receptors, potentially as a plant-based Selective Estrogen Receptor Modulator (phytoSERM).
© 2013.

Entities:  

Keywords:  Anti-atherogenic; Chemical characterization; Glabridin; Metabolic syndrome; Pharmacokinetics; PhytoSERM

Mesh:

Substances:

Year:  2013        PMID: 23850540      PMCID: PMC3795865          DOI: 10.1016/j.fitote.2013.07.003

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  87 in total

1.  Mutual interaction of special phytoestrogenic compounds, their synthetic carboxy-derivatives and the less-calcemic vitamin D analog activities in human derived female cultured osteoblasts.

Authors:  D Somjen; S Katzburg; O Sharon; G H Posner; N Jaccard; D Hendel; S Tamir; J Vaya
Journal:  J Steroid Biochem Mol Biol       Date:  2011-07-23       Impact factor: 4.292

2.  18beta-glycyrrhetinic acid and glabridin prevent oxidative DNA fragmentation in UVB-irradiated human keratinocyte cultures.

Authors:  Eugenia Veratti; Tiziana Rossi; Stefania Giudice; Luisa Benassi; Giorgia Bertazzoni; Daria Morini; Paola Azzoni; Elisa Bruni; Alberto Giannetti; Cristina Magnoni
Journal:  Anticancer Res       Date:  2011-06       Impact factor: 2.480

3.  Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans.

Authors:  Céline Messier; Daniel Grenier
Journal:  Mycoses       Date:  2011-05-25       Impact factor: 4.377

4.  Dual inhibitory effect of Glycyrrhiza glabra (GutGard™) on COX and LOX products.

Authors:  C V Chandrasekaran; H B Deepak; P Thiyagarajan; S Kathiresan; Gopal Krishna Sangli; M Deepak; Amit Agarwal
Journal:  Phytomedicine       Date:  2010-09-22       Impact factor: 5.340

5.  Antimicrobial activity of licorice flavonoids against methicillin-resistant Staphylococcus aureus.

Authors:  Toshio Fukai; Ai Marumo; Kiyoshi Kaitou; Toshihisa Kanda; Sumio Terada; Taro Nomura
Journal:  Fitoterapia       Date:  2002-10       Impact factor: 2.882

6.  Factors influencing glabridin stability.

Authors:  Mingzhang Ao; Yue Shi; Yongming Cui; Wentao Guo; Jing Wang; Longjiang Yu
Journal:  Nat Prod Commun       Date:  2010-12       Impact factor: 0.986

7.  Antioxidant effect of polyphenolic glabridin on LDL oxidation.

Authors:  E Carmeli; Y Fogelman
Journal:  Toxicol Ind Health       Date:  2009 May-Jun       Impact factor: 2.273

8.  Structural aspects of the inhibitory effect of glabridin on LDL oxidation.

Authors:  P A Belinky; M Aviram; S Mahmood; J Vaya
Journal:  Free Radic Biol Med       Date:  1998-06       Impact factor: 7.376

9.  Synthesis of glabridin derivatives as tyrosinase inhibitors.

Authors:  Warunee Jirawattanapong; Ekarin Saifah; Chamnan Patarapanich
Journal:  Arch Pharm Res       Date:  2009-05-27       Impact factor: 4.946

10.  Extraction of glycyrrhizic acid and glabridin from licorice.

Authors:  Minglei Tian; Hongyuan Yan; Kyung Ho Row
Journal:  Int J Mol Sci       Date:  2008-04-16       Impact factor: 6.208

View more
  30 in total

1.  Downregulation of iNOS and elevation of cAMP mediate the anti-inflammatory effect of glabridin in rats with ulcerative colitis.

Authors:  Nahla E El-Ashmawy; Naglaa F Khedr; Hoda A El-Bahrawy; Samar A El-Adawy
Journal:  Inflammopharmacology       Date:  2017-07-13       Impact factor: 4.473

Review 2.  Lessons from Nature: Sources and Strategies for Developing AMPK Activators for Cancer Chemotherapeutics.

Authors:  Richard T Arkwright; Rahul Deshmukh; Nikhil Adapa; Ryan Stevens; Emily Zonder; Zhongyu Zhang; Pershang Farshi; Reda Saber Ibrahim Ahmed; Hossny Awad El-Banna; Tak-Hang Chan; Q Ping Dou
Journal:  Anticancer Agents Med Chem       Date:  2015       Impact factor: 2.505

3.  Design and synthesis of novel 2,2-dimethylchromene derivatives as potential antifungal agents.

Authors:  Yong Li; Bilan Luo; Zhongfu Luo; Taigui Ma; Lingling Fan; Wenjing Liu; Judi Fan; Bing Guo; Wei Xue; Lei Tang
Journal:  Mol Divers       Date:  2022-05-31       Impact factor: 2.943

4.  Metabolic Profiling of Glabridin in Rat Plasma, Urine, Bile, and Feces After Intragastric and Intravenous Administration.

Authors:  Shundi Liu; Hao Lin; Yu Chen; Yuzhen Wang; Xiaoshan Zhang; Zheng Xiang; Xiaojun Cai
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2022-09-15       Impact factor: 2.569

5.  Combined Analysis of Pharmaceutical Active Ingredients and Transcriptomes of Glycyrrhiza uralensis Under PEG6000-Induced Drought Stress Revealed Glycyrrhizic Acid and Flavonoids Accumulation via JA-Mediated Signaling.

Authors:  Hua Yao; Fei Wang; Quan Bi; Hailiang Liu; Li Liu; Guanghui Xiao; Jianbo Zhu; Haitao Shen; Hongbin Li
Journal:  Front Plant Sci       Date:  2022-06-13       Impact factor: 6.627

6.  Absolute configuration of naturally occurring glabridin.

Authors:  Charlotte Simmler; Frank R Fronczek; Guido F Pauli; Bernard D Santarsiero
Journal:  Acta Crystallogr C       Date:  2013-10-09       Impact factor: 1.172

7.  In Silico and In Vivo Studies on the Mechanisms of Chinese Medicine Formula (Gegen Qinlian Decoction) in the Treatment of Ulcerative Colitis.

Authors:  Xiaolu Liu; Yuling Fan; Lipeng Du; Zhigang Mei; Yang Fu
Journal:  Front Pharmacol       Date:  2021-06-11       Impact factor: 5.810

8.  Galloyl-RGD as a new cosmetic ingredient.

Authors:  Dae-Hun Park; Dae Hyun Jung; Soo Jung Kim; Sung Han Kim; Kyung Mok Park
Journal:  BMC Biochem       Date:  2014-08-08       Impact factor: 4.059

9.  Commentary: The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb.

Authors:  Salvatore Chirumbolo
Journal:  Front Microbiol       Date:  2016-04-18       Impact factor: 5.640

10.  Glabridin-induced vasorelaxation: Evidence for a role of BKCa channels and cyclic GMP.

Authors:  Debrabata Chanda; Jesus Prieto-Lloret; Arjun Singh; Hina Iqbal; Pankaj Yadav; Vladimir Snetkov; Philip I Aaronson
Journal:  Life Sci       Date:  2016-09-26       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.